At study entry, patients demonstrated immune compromise consistent with prior standard of care, including radiation and alkylating chemotherapy. The baseline mean absolute lymphocyte count (ALC) was ...

Impact of 24 months of androgen deprivation therapy (ADT) on physical function in men with nonmetastatic prostate cancer. A phase II study of neoadjuvant docetaxel (D) plus bevacizumab (B) in patients ...

Please provide your email address to receive an email when new articles are posted on . Lymphopenia at diagnosis or during follow-up can predict OS among patients with multiple myeloma. Researchers ...

Identification of functional DNA methylation aberrations associated with outcome in melanoma patients with brain metastasis. This is an ASCO Meeting Abstract from the 2013 ASCO Annual Meeting I. This ...

The standard of care for NSCLC is definitive chemoradiation with consolidative immunotherapy; however, treatment-related lymphopenia may result in poorer patient outcomes. Severe lymphopenia at time ...

(A) Principal component analysis (PCA) of lymphocyte subsets and factors such as age in Control, LC, and LC-PTB groups, and the joint analysis of LC & LC-PTB. PC1 and PC2 represent the first and ...

ImmunityBio, Inc. (NASDAQ: IBRX), a commercial-stage immunotherapy company developing cytokine and cellular immunotherapies designed to restore immune competence, today announced updated Phase 2 ...